Clinical trial
The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk…
NCT00225108 · Ottawa Hospital Research Institute, Other · Completed
Key facts
| NCT number | NCT00225108 |
|---|---|
| Title | The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section |
| Official title | The Cesarean Section Thromboprophylaxis Pilot Study:A Randomized Open-Label Controlled Pilot Study of Prophylactic Low Molecular Weight Heparin in High Risk Postpartum Women Following Cesarean Section |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Collaborators | LEO Pharma Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Deep Vein Thrombosis |
| Intervention type | Drug |
| Interventions | Tinzaparin |
| Enrollment | 30 |
| Start date | Jul 1, 2002 |
| Completion | Sep 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 7, 2018 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: